DaVita HealthCare Partners Inc. (NYSE:DVA) announced that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, Feb. 12, 2015, at 5:00 p.m. Eastern Time. On Friday shares of DaVita HealthCare Partners Inc. (NYSE:DVA) closed at $75.05. Company’s sales growth for last 5 years was 15.80% and EPS growth for next 5 years is recorded as 8.11%.
HealthSouth Corp (NYSE:HLS) has traded 0.65% of the total shares outstanding in the last 20 days. The average daily volume for the preceding 20 days is 574,110shares. The short ratio for the counter is 8.08. The short interest has changed by 0.41% in the past 1 month. The 3-month % change in short interest is -0.09%. HEALTHSOUTH Corp. (NYSE:HLS) in last trading activity advanced 2.94% to close at $41.00. Company weekly performance is 3.77% while its quarterly performance stands at 6.60%. HEALTHSOUTH Corp. (NYSE:HLS) is -2.76% away from its 52 week high.
On January 9, Omnicare, Inc. (NYSE:OCR) announced an adjustment to the conversion rate of its 3.25% Convertible Senior Debentures due 2035 and its 3.25% Convertible Senior Exchange Debentures due 2035 (collectively, the “2035 Debentures”). Effective December 17, 2014, the adjusted conversion rate for the 2035 Debentures is 12.9869 shares of common stock per $1,000 principal amount, or approximately $77.00 per share. On last trading day Omnicare Inc. (NYSE:OCR) advanced 1.42% to close at $74.33. Its volatility for the week is 1.65% while volatility for the month is 1.61%. OCR’s sales growth for past 5 years was -0.60% and its EPS growth for past 5 years was -8.60%. Omnicare Inc. (NYSE:OCR) monthly performance is 5.79%.
On January 5, MEDNAX Inc. (NYSE:MD) announced the acquisition of Metropolitan Anesthesia Alliance, PLLC, a private physician group practice based in Memphis, Tenn. The practice will become part of MEDNAX’s American Anesthesiology division. The practice’s anesthesia services include general surgery, cardiac, vascular, orthopedic, neurosurgery (including spine), obstetric, pediatric and acute pain management. MEDNAX noted that this was a cash transaction, and is expected to be immediately accretive to earnings. MEDNAX, Inc. (NYSE:MD) has 1.50% insider ownership. In last trading activity company’s stock closed at $65.26.
Acadia Healthcare Company Inc (NASDAQ:ACHC) has received a consensus recommendation of “Buy” from the eight analysts that are covering the stock, Analyst Ratings News reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. On last trading day Acadia Healthcare Company, Inc. (NASDAQ:ACHC) advanced 0.13% to close at $59.14. Its volatility for the week is 3.30% while volatility for the month is 2.89%. ACHC’s sales growth for past 5 years was 86.60% and its EPS growth for past 5 years was 63.10%. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) monthly performance is -0.05%.